Hyperdiluted calcium hydroxylapatite for skin laxity and cellulite of the skin above the knee: A pilot study

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Stefania Guida ◽  
Sabrina Longhitano ◽  
Kaleci Shaniko ◽  
Hassan Galadari ◽  
Johanna Chester ◽  
...  
Keyword(s):  
Pilot Study ◽  
Skin Laxity ◽  
Calcium Hydroxylapatite

Hyperdiluted Calcium Hydroxylapatite for the Treatment of Skin Laxity of the Neck

2021 ◽  
Author(s):  
Stefania Guida ◽  
Sabrina Longhitano ◽  
Marco Spadafora ◽  
Andrea Lazzarotto ◽  
Francesca Farnetani ◽  
...  
Keyword(s):  
Skin Laxity ◽  
Calcium Hydroxylapatite

Using the BODY-Q to Evaluate Appearance and Quality of Life Following Treatment of Skin Laxity of the Outer Thigh with Microfocused Ultrasound and Calcium Hydroxylapatite

2019 ◽  
Vol 40 (11) ◽  
pp. 1219-1231
Author(s):  
Jesse R Smith ◽  
Michael Sheehan ◽  
Laurie A Casas
Keyword(s):  
Quality Of Life ◽  
The Body ◽  
Level Of Evidence ◽  
Skin Laxity ◽  
Excess Skin ◽  
Calcium Hydroxylapatite ◽  
Female Patients ◽  
Lidocaine Solution

Abstract Background Two procedures that have demonstrated collagen-stimulating properties and improvements in skin laxity in a variety of aesthetic indications are microfocused ultrasound with visualization (MFU-V) and injection with calcium hydroxylapatite (CaHA). Objectives By treating skin laxity with a combination of these therapies, it was hypothesized that our patients would experience improved appearance and quality of life as measured by the BODY-Q. Methods A total of 60 consecutive female patients aged 30 to 60 years with body mass index less than 28 kg/m2 who expressed interest in treatment for skin laxity affecting the outer thighs completed selected scales (Body Image, Appraisal of Excess Skin, Satisfaction with Hips and Outer Thighs, and Appearance-Related Psychosocial Distress) from the BODY-Q within 1 week of treatment. At the time of treatment, MFU-V was directed to the outer thighs (150 lines at focal depths of 3.0 and 4.5 mm per outer thigh). Immediately following MFU-V, patients received treatment with CaHA injected into the subdermis (1.5 mL diluted 1:1 with 1.5 mL of 2% lidocaine solution per outer thigh). At 90 days posttreatment, these patients repeated the BODY-Q. Results At 90 days posttreatment, with 100% follow-up among the 60 consecutive female patients treated, scores from the BODY-Q scales showed statistically significant improvement (P < 0.01). Conclusions Following treatment of skin laxity on the outer thighs with a combination of MFU-V and CaHA, our patients reported a statistically significant improvement in appearance and quality of life at 90 days posttreatment. This protocol may be applicable to other areas of the body. Level of Evidence: 4

Sign in / Sign up

Export Citation Format

Share Document